Craig Hauser, Ph.D.
Craig Hauser's Research Focus
Dr. Hauser’s research has centered on the interplay between the regulation of gene expression and oncogenic transformation. A major focus has been determining the role of the Ets family of transcription factors in cancer. His work has defined several distinct roles for Ets factors in mediating the many features of cellular transformation, and revealed unanticipated complexity in this transcription factor gene family.
Craig Hauser's Bio
Dr. Hauser earned his Ph.D. in Molecular Genetics from University of California at Irvine. Following postdoctoral training at UC Berkeley, Dr. Hauser was recruited to the Sanford-Burnham faculty in 1989, and was promoted to Associate Professor in 1996. In 2005, he became an adjunct faculty member and assumed a full-time administrative role. Dr. Hauser currently serves as Vice President for Scientific Resources, and as Cancer Center Associate Director, Shared Resources, overseeing Sanford Burnham Prebys’ Shared Resource operations, scientific equipment, and scientific regulatory compliance.
Publications
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements.
MAQC Consortium., Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, Collins PJ, de Longueville F, Kawasaki ES, Lee KY, Luo Y, Sun YA, Willey JC, Setterquist RA, Fischer GM, Tong W, Dragan YP, Dix DJ, Frueh FW, Goodsaid FM, Herman D, Jensen RV, Johnson CD, Lobenhofer EK, Puri RK, Schrf U, Thierry-Mieg J, Wang C, Wilson M, Wolber PK, Zhang L, Amur S, Bao W, Barbacioru CC, Lucas AB, Bertholet V, Boysen C, Bromley B, Brown D, Brunner A, Canales R, Cao XM, Cebula TA, Chen JJ, Cheng J, Chu TM, Chudin E, Corson J, Corton JC, Croner LJ, Davies C, Davison TS, Delenstarr G, Deng X, Dorris D, Eklund AC, Fan XH, Fang H, Fulmer-Smentek S, Fuscoe JC, Gallagher K, Ge W, Guo L, Guo X, Hager J, Haje PK, Han J, Han T, Harbottle HC, Harris SC, Hatchwell E, Hauser CA, Hester S, Hong H, Hurban P, Jackson SA, Ji H, Knight CR, Kuo WP, LeClerc JE, Levy S, Li QZ, Liu C, Liu Y, Lombardi MJ, Ma Y, Magnuson SR, Maqsodi B, McDaniel T, Mei N, Myklebost O, Ning B, Novoradovskaya N, Orr MS, Osborn TW, Papallo A, Patterson TA, Perkins RG, Peters EH, Peterson R, Philips KL, Pine PS, Pusztai L, Qian F, Ren H, Rosen M, Rosenzweig BA, Samaha RR, Schena M, Schroth GP, Shchegrova S, Smith DD, Staedtler F, Su Z, Sun H, Szallasi Z, Tezak Z, Thierry-Mieg D, Thompson KL, Tikhonova I, Turpaz Y, Vallanat B, Van C, Walker SJ, Wang SJ, Wang Y, Wolfinger R, Wong A, Wu J, Xiao C, Xie Q, Xu J, Yang W, Zhang L, Zhong S, Zong Y, Slikker W Jr
Nat Biotechnol 2006 Sep ;24(9):1151-61
The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.
Noren NK, Foos G, Hauser CA, Pasquale EB
Nat Cell Biol 2006 Aug ;8(8):815-25
Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors.
Galang CK, Muller WJ, Foos G, Oshima RG, Hauser CA
J Biol Chem 2004 Mar 19 ;279(12):11281-92
The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.
Noren NK, Foos G, Hauser CA, Pasquale EB
Nat Cell Biol 2006 Aug ;8(8):815-25
Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer.
Liu M, Howes A, Lesperance J, Stallcup WB, Hauser CA, Kadoya K, Oshima RG, Abraham RT
Cancer Res 2005 Jun 15 ;65(12):5325-36
Angiogenic acceleration of Neu induced mammary tumor progression and metastasis.
Oshima RG, Lesperance J, Munoz V, Hebbard L, Ranscht B, Sharan N, Muller WJ, Hauser CA, Cardiff RD
Cancer Res 2004 Jan 1 ;64(1):169-79
Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors.
Galang CK, Muller WJ, Foos G, Oshima RG, Hauser CA
J Biol Chem 2004 Mar 19 ;279(12):11281-92
Ets2-dependent stromal regulation of mouse mammary tumors.
Man AK, Young LJ, Tynan JA, Lesperance J, Egeblad M, Werb Z, Hauser CA, Muller WJ, Cardiff RD, Oshima RG
Mol Cell Biol 2003 Dec ;23(23):8614-25
Ets2 is not required for Ras or Neu/ErbB-2 mediated cellular transformation in vitro.
Hevér A, Oshima RG, Hauser CA
Exp Cell Res 2003 Oct 15 ;290(1):132-43
